Skip to main content
. 2021 Mar 10;12:628970. doi: 10.3389/fphar.2021.628970

TABLE 5.

In vitro interaction of 4-chlorothymol with chloroquine at different concentrations against chloroquine-resistant strain (K1) of P. falciparum.

Fix ratio *IC50 (µg/ml) *FIC50 ƩFIC50 #Interactions
Chloroquine 4-Chlorothymol Chloroquine 4-Chlorothymol
5:0 0.130 ± 0.04 (0.252 µM)
4:1 0.057 ± 0.010 (0.110 µM) 0.287 ± 0.078 (1.559 µM) 0.438 ± 0.078 0.119 ± 0.032 0.558 Synergistic
3:2 0.041 ± 0.011 (0.079 µM) 0.600 ± 0.119 (3.260 µM) 0.320 ± 0.091 0.250 ± 0.049 0.570 Synergistic
1:1 0.027 ± 0.002 (0.052 µM) 0.745 ± 0.268 (4.048 µM) 0.207 ± 0.022 0.310 ± 0.111 0.518 Synergistic
2:3 0.023 ± 0.008 (0.044 µM) 0.875 ± 0.166 (4.755 µM) 0.179 ± 0.006 0.364 ± 0.069 0.544 Synergistic
1:4 0.015 ± 0.002 (0.029 µM) 1.225 ± 0.132 (6.657 µM) 0.117 ± 0.020 0.510 ± 0.055 0.628 Synergistic
0:5 2.40 ± 0.42 (13.043 µM)

FIC50 = IC50 in combination/IC50 of drug alone and ƩFIC50 = FIC50 values of chloroquine + FIC50 values of 4-chlorothymol at different ratio. *IC50 and *FIC50 expressed as mean ± SEM (n = 3), and #Σ FIC <1 synergism, Σ FIC ≥1 and <2 additive, Σ FIC ≥2 and <4 antagonism.